Overview
Neurosarcoidosis (NS) is a complex inflammatory disorder characterized by granulomatous lesions affecting the central nervous system (CNS), leading to diverse neurological manifestations including headache, cranial nerve palsies, seizures, and visual disturbances 1.Diagnosis
Clinical Presentation: Headache, papilledema, facial palsy, seizures, motor deficits 1.
Neurological Examination: Often reveals signs of meningitis and cranial nerve involvement 1.
Imaging: MRI may show characteristic lesions; CSF analysis typically demonstrates pleocytosis with elevated white blood cell counts 1.
Ophthalmologic Involvement: Bilateral granulomatous uveitis is common 1.
CSF Analysis: Elevated WBC counts (6-70 cells/mm3) indicative of meningeal involvement 1.
Histopathology: Definitive diagnosis often requires biopsy showing non-caseating granulomas 1.Management
First-Line Treatments: Corticosteroids are typically initiated for acute presentations 1.
Adjunctive Therapies: Immunosuppressive agents such as methotrexate or azathioprine may be used for refractory cases 1.
Monitoring: Regular neurological and ophthalmologic evaluations to monitor disease progression and treatment efficacy 1.Special Populations
Pediatrics: Diagnosis and management in children present unique challenges; predominant symptoms include headache and papilledema, often with significant eye involvement 1.Key Recommendations
Initiate corticosteroids for acute neurosarcoidosis presentations (Evidence: Moderate 1).
Consider immunosuppressive therapy for patients with refractory symptoms (Evidence: Moderate 1).
Regular multidisciplinary follow-up is essential for monitoring neurological and ophthalmologic outcomes (Evidence: Expert opinion 1).References
1 Tohme R, Tanase A, Dumaine C, Dusser P, Adle-Biassette H, Despert V et al.. Diagnostic and Therapeutic Insights Into Pediatric Neurosarcoidosis: Observations From French Pediatric Rheumatology Centers. Pediatric neurology 2025. link